Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film

Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film

Abstract Background Long-term use of topical, especially benzalkonium chloride (BAC)-preserved, antiglaucoma medications can cause a negative impact on the ocular surface. The aim of the study was to assess the effect of topical carbonic anhydrase inhibitors (CAIs) on selected oxidative stress bioma...

Full description

Bibliographic Details
Main Authors: Lech Sedlak, Marta Świerczyńska, Weronika Borymska, Maria Zych, Dorota Wyględowska-Promieńska
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Ophthalmology
Subjects:
Benzalkonium chloride
Dorzolamide
Brinzolamide
Carbonic anhydrase inhibitor
Oxidative stress
Ocular surface
Online Access:https://doi.org/10.1186/s12886-021-02079-y

Internet

https://doi.org/10.1186/s12886-021-02079-y

Similar Items